AstraZeneca, MRC Technology Partner With Charities on Lung Disease Research

News   Sep 01, 2016

 
AstraZeneca, MRC Technology Partner With Charities on Lung Disease Research
 
 
 

RELATED ARTICLES

Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

News

New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.

READ MORE

Autoimmune Drug Design Inspired by Viral Tricks

News

“Viruses find ways of turning off immune responses so they can avoid being recognized and attacked,” explains John Šedý, Ph.D., research assistant professor at SBP and lead author of the study. “We looked at the proteins that herpes viruses use to turn down the immune system to figure out how to make a new drug to treat autoimmune disorders.”

READ MORE

New Cell-weighing Technique Helps Predict How Drugs Affect Cancer Cells

News

Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE